Dry Eye Market by Drug Class (Anti-Inflammatory Agents, Topical Corticosteroids, Artificial Tears, Oral Omega Supplements, and Others), by Disease Type (Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome), by Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, and Online Pharmacies) – Global Outlook & Forecast Period 2022-2030

GR - 713669 Category: Pharmaceuticals
Dry Eye Market by Drug Class (Anti-Inflammatory Agents, Topical Corticosteroids, Artificial Tears, Oral Omega Supplements, and Others), by Disease Type (Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome), by Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, and Online Pharmacies) – Global Outlook & Forecast Period 2022-2030

Number of pages: 100  |  Report Format: PDF  |  Published date: 17 November, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030



Single User License
Single User License
Multi User License
Enterprise User License
Data Pack License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities

GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach